Join us on January 12, 2022, at 1pm ET / 10am PT, for an online conversation with one of the world’s leading cancer immunotherapy scientists, who will talk about the exciting progress to come in the year ahead in advancing cancer patient treatment.
During this free webinar for patients and caregivers, viewers will learn about:
- Promising new treatment strategies in patient care including combination treatments
- What biomarkers are and how they’re important to formulating a treatment plan
- Latest advances in cellular immunotherapy for solid tumors
This webinar features renowned cancer immunotherapy expert E. John Wherry, Ph.D., the director of the Institute for Immunology, the chair of the Department of Systems Pharmacology and Translational Therapeutics, and the Richard and Barbara Schiffrin President’s Distinguished Professor at the University of Pennsylvania Perelman School of Medicine. He is also an associate director of the Cancer Research Institute Scientific Advisory Council. A leader in understanding T cell biology in the context of chronic infection and cancer, Dr. Wherry has published more than 200 papers and his research has been cited nearly 50,000 times in peer-reviewed publications.
Cancer Immunotherapy and You Webinars™ are produced by the Cancer Research Institute and hosted by CRI Assistant Director of Scientific Content Arthur N. Brodsky, Ph.D. The 2022 series is made possible with generous support from Bristol Myers Squibb and Lilly Oncology.
Browse our Cancer Immunotherapy and You Webinars playlist on YouTube or visit the Webinars page on our website to see other webinars in this series.